Our scientific and marketing teams have just completed the finishing touches on our latest whitepaper which outlines the principle benefits of using lyophilised reagent beads to stabilise in vitro diagnostic assays.
The 24 Page document explains how the single dose nature of a bead delivers benefits in dosage consistency, speed of reconstitution and reduced risk of contamination and wastage, as well as a number of manufacturing efficiency benefits.
The whitepaper is available to download here
Comments are closed.
